These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24833293)

  • 1. Eye diseases: a new use for interleukin-18 in sight.
    Bray N
    Nat Rev Drug Discov; 2014 Jun; 13(6):418. PubMed ID: 24833293
    [No Abstract]   [Full Text] [Related]  

  • 2. IL-18 is not therapeutic for neovascular age-related macular degeneration.
    Hirano Y; Yasuma T; Mizutani T; Fowler BJ; Tarallo V; Yasuma R; Kim Y; Bastos-Carvalho A; Kerur N; Gelfand BD; Bogdanovich S; He S; Zhang X; Nozaki M; Ijima R; Kaneko H; Ogura Y; Terasaki H; Nagai H; Haro I; Núñez G; Ambati BK; Hinton DR; Ambati J
    Nat Med; 2014 Dec; 20(12):1372-5. PubMed ID: 25473914
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to IL-18 is not therapeutic for neovascular age-related macular degeneration.
    Doyle SL; Adamson P; López FJ; Humphries P; Campbell M
    Nat Med; 2014 Dec; 20(12):1376-7. PubMed ID: 25473915
    [No Abstract]   [Full Text] [Related]  

  • 4. IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration.
    Doyle SL; Ozaki E; Brennan K; Humphries MM; Mulfaul K; Keaney J; Kenna PF; Maminishkis A; Kiang AS; Saunders SP; Hams E; Lavelle EC; Gardiner C; Fallon PG; Adamson P; Humphries P; Campbell M
    Sci Transl Med; 2014 Apr; 6(230):230ra44. PubMed ID: 24695684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic approaches for vision loss due to choroidal neovascularizations in age related macular degeneration.
    Costagliola C
    Curr Drug Targets; 2011 Feb; 12(2):133-7. PubMed ID: 20887248
    [No Abstract]   [Full Text] [Related]  

  • 6. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
    Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG
    Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration.
    Barouch FC; Miller JW
    Int Ophthalmol Clin; 2004; 44(3):23-32. PubMed ID: 15211174
    [No Abstract]   [Full Text] [Related]  

  • 8. Is IL-10 a good target to inhibit choroidal neovascularisation in age-related macular disease?
    Lightman S; Calder V
    PLoS Med; 2006 Aug; 3(8):e364. PubMed ID: 16903781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
    Bressler NM
    Am J Ophthalmol; 2002 Jan; 133(1):168-9. PubMed ID: 11755871
    [No Abstract]   [Full Text] [Related]  

  • 10. The new face of age-related macular degeneration.
    Giuliari GP; Ciardella AP
    Can J Ophthalmol; 2007 Aug; 42(4):629-30. PubMed ID: 17641716
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new treatment for ocular neovascularization.
    Ferris FL
    N Engl J Med; 2004 Dec; 351(27):2863-5. PubMed ID: 15625339
    [No Abstract]   [Full Text] [Related]  

  • 13. A very effective treatment for neovascular macular degeneration.
    Stone EM
    N Engl J Med; 2006 Oct; 355(14):1493-5. PubMed ID: 17021326
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial: update on the modern management of wet age-related macular degeneration.
    Devenyi RG
    Can J Ophthalmol; 2006 Apr; 41(2):133-8. PubMed ID: 16767199
    [No Abstract]   [Full Text] [Related]  

  • 15. [Photodynamic therapy for choroidal neovascularizations in age-related macular degeneration].
    Valmaggia C
    Praxis (Bern 1994); 2006 Feb; 95(7):238-40. PubMed ID: 16524114
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
    Bom Aggio F; Eid Farah M; Melo GB
    Acta Ophthalmol Scand; 2006 Oct; 84(5):713-4. PubMed ID: 16965511
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Isola V; Pece A; Brancato R
    Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088
    [No Abstract]   [Full Text] [Related]  

  • 18. Towards a rational approach to combination therapy for neovascular age-related macular degeneration.
    Arroyo JG
    Br J Ophthalmol; 2007 Feb; 91(2):130-1. PubMed ID: 17244655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.
    Du H; Sun X; Guma M; Luo J; Ouyang H; Zhang X; Zeng J; Quach J; Nguyen DH; Shaw PX; Karin M; Zhang K
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2377-82. PubMed ID: 23341606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimonthly injections of ranibizumab for age-related macular degeneration.
    Ilhan A; Tas A; Yolcu U; Gundogan FC
    Graefes Arch Clin Exp Ophthalmol; 2015 May; 253(5):823. PubMed ID: 25488573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.